1 Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
2 Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan.
Tissue Eng Part A. 2019 Feb;25(3-4):183-192. doi: 10.1089/ten.TEA.2018.0109. Epub 2018 Dec 28.
Although transplantation of islets of Langerhans has been accepted as a fundamental treatment for insulin-dependent diabetes mellitus (IDDM), several problems are still remaining in order that it becomes the standard medical treatment of IDDM patients. In this study, using diabetic rat models, a subcutaneous space surrounded with highly vascularized granulomatous tissue was formed by agarose-bFGF rod implantation. Allogeneic islets transplanted into the space could survive and release insulin for a long period under no immunosuppressive medication. In conjunction with sufficient supply of islets from iPS/ES cells, our method can make islet transplantation the standard medical treatment of IDDM patients.
虽然胰岛细胞移植已被接受为胰岛素依赖型糖尿病(IDDM)的基本治疗方法,但为了使其成为 IDDM 患者的标准治疗方法,仍存在一些问题。在这项研究中,使用糖尿病大鼠模型,通过琼脂糖-bFGF 棒植入在皮下形成一个充满高度血管化肉芽组织的空间。同种异体胰岛移植到该空间后,在没有免疫抑制药物的情况下可以长期存活并释放胰岛素。结合从 iPS/ES 细胞中获得足够的胰岛供应,我们的方法可以使胰岛移植成为 IDDM 患者的标准治疗方法。